United States · FDA National Drug Code directory

Pantoprazole Sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
85534-0061_5522a929-a1b7-d0e4-e063-6394a90ae106
Product NDC
85534-0061
Form
TABLET, DELAYED RELEASE
Composition / generic term
Pantoprazole Sodium
Labeler
HAWAII REPACK, INC.
Marketing category
ANDA
Marketing start / end (source format)
20120928
Source listing expiry
20271231

Source-listed ingredients

  • PANTOPRAZOLE SODIUM — 40 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 TABLET, DELAYED RELEASE in 1 BOTTLE (85534-0061-0) · 85534-0061-0
  • 20 TABLET, DELAYED RELEASE in 1 BOTTLE (85534-0061-1) · 85534-0061-1
  • 30 TABLET, DELAYED RELEASE in 1 BOTTLE (85534-0061-2) · 85534-0061-2
  • 60 TABLET, DELAYED RELEASE in 1 BOTTLE (85534-0061-3) · 85534-0061-3
  • 90 TABLET, DELAYED RELEASE in 1 BOTTLE (85534-0061-4) · 85534-0061-4
  • 120 TABLET, DELAYED RELEASE in 1 BOTTLE (85534-0061-5) · 85534-0061-5

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →